Steve Harvey, MD, discusses the challenges of defining treatment resistant depression and provides and overview of treatment options.
Treatment Resistant Depression
William M. Sauve, MD, reviews the landscape of delivery mechanisms for ketamine agents, including intravenous, sublingual, and intramuscular.
Hanita Chhabra, MD, highlights safety and efficacy data of esketamine and shares practical implications for clinical practice.
Geoffrey Grammer, MD, offers guidance on navigating challenges such as elevated blood pressure and substance misuse and abuse regarding the use of esketamine.
Advertisement
Advertisement
Trending on HCPLive
1
Beyond Atherosclerosis: Coronary Calcium Scoring in Dyslipidemia, CKM Syndrome
2
Q&A: Where is Vitiligo Headed in 2026? With Davinder Parsad, MD
3
Chronic Hypoparathyroidism Today: Unmet Needs, Conventional Therapy Limits, and the Shift to PTH Replacement
4
The HCPFive: Top News for Healthcare Providers from the Week of 07/05
5